154 related articles for article (PubMed ID: 23791518)
21. [Pharmacological and clinical profiles of miglustat (Brazaves(®)) for the treatment of Niemann-Pick type C disease].
Kitatani T; Takahashi S; Ikenoya S
Nihon Yakurigaku Zasshi; 2013 Mar; 141(3):160-7. PubMed ID: 23470482
[No Abstract] [Full Text] [Related]
22. Miglustat Does Not Prevent Neurological Involvement in Niemann Pick C Disease.
Di Rocco M; Barone R; Madeo A; Fiumara A
Pediatr Neurol; 2015 Oct; 53(4):e15. PubMed ID: 26255750
[No Abstract] [Full Text] [Related]
23. Miglustat in patients with Niemann-Pick disease Type C (NP-C): a multicenter observational retrospective cohort study.
Pineda M; Wraith JE; Mengel E; Sedel F; Hwu WL; Rohrbach M; Bembi B; Walterfang M; Korenke GC; Marquardt T; Luzy C; Giorgino R; Patterson MC
Mol Genet Metab; 2009 Nov; 98(3):243-9. PubMed ID: 19656703
[TBL] [Abstract][Full Text] [Related]
24. Motion analysis of a child with Niemann-Pick disease type C treated with miglustat.
Paciorkowski AR; Westwell M; Ounpuu S; Bell K; Kagan J; Mazzarella C; Greenstein RM
Mov Disord; 2008 Jan; 23(1):124-8. PubMed ID: 17973331
[TBL] [Abstract][Full Text] [Related]
25. Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect.
Nadjar Y; Hütter-Moncada AL; Latour P; Ayrignac X; Kaphan E; Tranchant C; Cintas P; Degardin A; Goizet C; Laurencin C; Martzolff L; Tilikete C; Anheim M; Audoin B; Deramecourt V; De Gaillarbois TD; Roze E; Lamari F; Vanier MT; Héron B
Orphanet J Rare Dis; 2018 Oct; 13(1):175. PubMed ID: 30285904
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal changes in cerebellar and subcortical volumes in adult-onset Niemann-Pick disease type C patients treated with miglustat.
Bowman EA; Walterfang M; Abel L; Desmond P; Fahey M; Velakoulis D
J Neurol; 2015 Sep; 262(9):2106-14. PubMed ID: 26092521
[TBL] [Abstract][Full Text] [Related]
27. Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study.
Patterson MC; Mengel E; Vanier MT; Schwierin B; Muller A; Cornelisse P; Pineda M;
Orphanet J Rare Dis; 2015 May; 10():65. PubMed ID: 26017010
[TBL] [Abstract][Full Text] [Related]
28. Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C.
Fecarotta S; Romano A; Della Casa R; Del Giudice E; Bruschini D; Mansi G; Bembi B; Dardis A; Fiumara A; Di Rocco M; Uziel G; Ardissone A; Roccatello D; Alpa M; Bertini E; D'Amico A; Dionisi-Vici C; Deodato F; Caviglia S; Federico A; Palmeri S; Gabrielli O; Santoro L; Filla A; Russo C; Parenti G; Andria G
Orphanet J Rare Dis; 2015 Feb; 10():22. PubMed ID: 25888393
[TBL] [Abstract][Full Text] [Related]
29. [Therapies in the Niemann-Pick type C disease].
Chabrol B
Arch Pediatr; 2010 Jun; 17 Suppl 2():S54-7. PubMed ID: 20620897
[TBL] [Abstract][Full Text] [Related]
30. Long-term therapy with miglustat and cognitive decline in the adult form of Niemann-Pick disease type C: a case report.
Tozza S; Dubbioso R; Iodice R; Topa A; Esposito M; Ruggiero L; Spina E; De Rosa A; Saccà F; Santoro L; Manganelli F
Neurol Sci; 2018 Jun; 39(6):1015-1019. PubMed ID: 29536386
[TBL] [Abstract][Full Text] [Related]
31. Treatment of a child diagnosed with Niemann-Pick disease type C with miglustat: a case report in Brazil.
Santos ML; Raskin S; Telles DS; Löhr A; Liberalesso PB; Vieira SC; Cordeiro ML
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S357-61. PubMed ID: 18937049
[TBL] [Abstract][Full Text] [Related]
32. Niemann-Pick type C: a potentially treatable disorder?
Kheder A; Scott C; Olpin S; Hadjivassiliou M
Pract Neurol; 2013 Dec; 13(6):382-5. PubMed ID: 23906593
[TBL] [Abstract][Full Text] [Related]
33. Treatable metabolic psychoses that go undetected: what Niemann-Pick type C can teach us.
Klünemann HH; Santosh PJ; Sedel F
Int J Psychiatry Clin Pract; 2012 Sep; 16(3):162-9. PubMed ID: 22746831
[TBL] [Abstract][Full Text] [Related]
34. White and gray matter alterations in adults with Niemann-Pick disease type C: a cross-sectional study.
Scheel M; Abegg M; Lanyon LJ; Mattman A; Barton JJ
Neurology; 2011 Jan; 76(2):201; author reply 201-2. PubMed ID: 21220727
[No Abstract] [Full Text] [Related]
35. Eye movement and diffusion tensor imaging analysis of treatment effects in a Niemann-Pick Type C patient.
Scheel M; Abegg M; Lanyon LJ; Mattman A; Barton JJ
Mol Genet Metab; 2010 Mar; 99(3):291-5. PubMed ID: 19939718
[TBL] [Abstract][Full Text] [Related]
36. Estimating the prevalence of Niemann-Pick disease type C (NPC) in the United States.
Burton BK; Ellis AG; Orr B; Chatlani S; Yoon K; Shoaff JR; Gallo D
Mol Genet Metab; 2021; 134(1-2):182-187. PubMed ID: 34304992
[TBL] [Abstract][Full Text] [Related]
37. Treatment of cataplexy in Niemann-Pick disease type C with the use of miglustat.
Zarowski M; Steinborn B; Gurda B; Dvorakova L; Vlaskova H; Kothare SV
Eur J Paediatr Neurol; 2011 Jan; 15(1):84-7. PubMed ID: 20207562
[TBL] [Abstract][Full Text] [Related]
38. Patient with Niemann-Pick disease type C: over 20 years' follow-up.
Abe K; Sakai N
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28830896
[TBL] [Abstract][Full Text] [Related]
39. Miglustat in Niemann-Pick disease type C patients: a review.
Pineda M; Walterfang M; Patterson MC
Orphanet J Rare Dis; 2018 Aug; 13(1):140. PubMed ID: 30111334
[TBL] [Abstract][Full Text] [Related]
40. Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial.
Wraith JE; Vecchio D; Jacklin E; Abel L; Chadha-Boreham H; Luzy C; Giorgino R; Patterson MC
Mol Genet Metab; 2010 Apr; 99(4):351-7. PubMed ID: 20045366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
